Skip to main content

Table 3 P-PKC and P-MARCKS expression

From: Neuroprotective effects of donepezil against Aβ25-35-induced neurotoxicity

Groups

P-PKC

P-MARCKS

Control

100

100

Donepezil

158.86 ± 11.62*

147.56 ± 12.05*

GF109203X + donepezil

99.67 ± 10.36**

99.64 ± 8.86**

GF109203X

95.47 ± 8.53

93.58 ± 7.36

P

0.001

0.015

  1. P-PKC phosphorylated protein kinase C; P-MARCKS phospho-myristoylated alanine-rich C kinase substrate
  2. *P < 0.05 compared with the control group, and **P < 0.05 compared with the donepezil group